Page last updated: 2024-08-17

nad and Alzheimer Disease

nad has been researched along with Alzheimer Disease in 56 studies

Research

Studies (56)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (3.57)18.2507
2000's12 (21.43)29.6817
2010's24 (42.86)24.3611
2020's18 (32.14)2.80

Authors

AuthorsStudies
Bormann, MK; Cohen, BM; Healy, RA; Lee, Y; Ryu, WI; Shen, M; Sonntag, KC1
Chan, ACY; Chen, MH; Herrmann, N; Krance, SH; Kwong, S; Lanctôt, KL; Ouk, M; Song, BX; Stanley, M; Swardfager, W; Wu, CY; Xiong, LY; Yung, A; Zhang, J1
Fathi, M; Hajibeygi, R; Jazi, K; Klegeris, A; McElhinney, A; Sayehmiri, F; Shool, S; Sodeifian, F; Tavasol, A; Tavirani, MR; Vakili, K; Yaghoobpoor, S1
Archa Rajagopal, J; Chase Barton, C; Davis Sanders, O; Lopez, K; Lopez, O; Malik, F; Rajagopal, L1
Bragin, DE; Bragina, OA; Kameneva, MV; Nemoto, EM; Sillerud, LO1
A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X1
Boufidou, F; Constantinides, VC; Kapaki, E; Karavasilis, E; Paraskevas, GP; Pyrgelis, ES; Stefanis, L; Tentolouris-Piperas, V; Toulas, P; Velonakis, G1
Mahley, RW1
Cartas-Cejudo, P; Fernández-Irigoyen, J; Ferrer, I; Lachén-Montes, M; Santamaría, E1
Abramowicz, M; Blouin, JL; Cattaneo, A; Coppola, L; Festari, C; Frisoni, GB; Lopizzo, N; Luongo, D; Marizzoni, M; Mazzelli, M; Mirabelli, P; Mombelli, E; Naviglio, D; Pievani, M; Salvatore, M1
Chen, C; Hu, Y; Huang, X; Shen, D; Xing, S1
Aman, Y; Bergersen, LH; Bohr, VA; Fang, EF; Frank, J; Lautrup, SH; Matysek, A; Nilsen, H; Niu, Z; Rasmussen, LJ; Shi, L; Storm-Mathisen, J; Yang, G1
Mattson, MP1
Xia, J; Xu, B; Zhao, N1
Chatton, JY; Gallart-Ayala, H; Ivanisevic, J; Maillard, V; Rosenberg, N; Teav, T; van der Velpen, V1
Chen, Z; Liang, Y; Tanzi, RE; Wang, C; Wey, HY; Xu, Y; Zhang, C1
Hosseini, L; Mahmoudi, J; Pashazadeh, F; Sadigh-Eteghad, S; Salehi-Pourmehr, H1
Celardo, I; Fedele, G; Loh, SHY; Martins, LM; Yu, Y1
Behrens, MI; Bruna, BA; Gómez-Virgilio, L; Luarte, A; Ponce, DP1
Alfano, R; Budansky, Y; Das, B; Rodriguez-Contreras, A; Shi, L1
Alfano, RR; Harvey, G; Harvey, T; Lu, L; Rodríguez-Contreras, A; Shi, L1
Qian, F; Ruan, J; Ruan, Q; Yu, Z; Zhang, W1
Bohr, VA; Croteau, DL; Demarest, TG; Fang, EF; Hou, Y; Lautrup, S; Mattson, MP1
Auwerx, J; Beck, JS; Counts, SE; D'Amico, D; Mouchiroud, L; Moullan, N; Potenza, F; Rietsch, S; Romani, M; Schmid, AW; Sorrentino, V; Zhang, H1
Braidy, N; Grant, R; Sachdev, PS1
Chowdhury, S; Haque, S; Mehedi, I; Nahid, NA; Poddar, SK; Sifat, AE1
Brewer, GJ; Digman, MA; Dong, Y1
Fang, EF1
Li, S; Nielsen, M; Shi, J; Yin, J1
Brewer, GJ; Dong, Y1
Brewer, GJ; Digman, MA; Dong, Y; Sameni, S1
Brewer, GJ; Ghosh, D; LeVault, KR1
Chi, Y; Sauve, AA1
Fishman, PS; Kristian, T; Long, AN; Owens, K; Schlappal, AE; Schuh, RA1
Hoth, JJ; Liu, T; McCall, CE; Vachharajani, VT; Wang, X; Yoza, BK1
Aitken, L; Gunn-Moore, FJ; Penedo, JC; Perez-Gonzalez, C; Quinn, SD; Samuel, ID1
Hu, X; Sakurai, T; Takata, T; Wang, X; Yang, Y1
Correani, V; d'Erme, M; Fontana, M; Forte, E; Fuso, A; Maras, B; Martire, S; Mosca, L; Scarpa, S1
Adams, JD1
Fivecoat, H; Ho, L; Ling, E; Pan, Y; Pasinetti, GM; Wang, J1
Aljada, A; Dong, L; Mousa, SA1
Abeti, R; Abramov, AY; Duchen, MR1
Barnett, AJ; Brewer, GJ; Ghosh, D; LeVault, KR1
Büchner, M; Huber, R; Riepe, MW; Staufenbiel, M; Sturchler-Pierrat, C1
Mazzola, JL; Sirover, MA1
Christie, R; Hyman, BT; Nikitin, AY; Webb, WW; Williams, RM; Zipfel, WR1
Butterfield, DA; Pocernich, CB1
Arancio, O; Caspersen, C; Chaney, M; Chen, X; Cirilli, M; Gunn-Moore, F; Kuppusamy, P; Lin, C; Liu, S; Lue, LF; Lustbader, JW; Pollak, S; Stern, D; Takuma, K; Trinchese, F; Walker, DG; Wang, N; Wu, H; Xu, HW; Yan, SS; Zewier, ZL1
Demarin, V; Kay, G; Podobnik, SS; Storga-Tomic, D1
Abreo, MA; Agree, CS; Aust, RM; Kissinger, CR; Li, B; Margosiak, S; Meng, JJ; Pelletier, LA; Rejto, PA; Showalter, RE; Tempczyk-Russell, A; Thomson, JA; Vanderpool, D; Villafranca, JE1
Adès, D; Garnier-Suillerot, A; Le Moyec, L; Migonney, V; Saengkhae, C; Salerno, M; Siove, A1
Dmitriev, LF1
Ohm, TG; Schägger, H1
Haushofer, M; Jellinger, KA; Kraxberger, E; Mucke, HA; Rainer, M1
He, XY; Lin, D; Mehta, P; Merz, G; Schulz, H; Wen, GY; Yang, SY; Yang, YZ1
Claassen, D; Martinez, AJ; Moossy, J; Rao, GR; Zubenko, GS1

Reviews

18 review(s) available for nad and Alzheimer Disease

ArticleYear
Endosomal-Lysosomal and Autophagy Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Journal of Alzheimer's disease : JAD, 2022, Volume: 88, Issue:4

    Topics: Alzheimer Disease; Autophagy; Biomarkers; Endosomes; Humans; Lysosomes; NAD

2022
Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
    Frontiers in immunology, 2022, Volume: 13

    Topics: 3-Hydroxyanthranilic Acid; Adenosine; Alzheimer Disease; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Kynurenic Acid; Kynurenine; NAD; Niacinamide; Parkinson Disease; Tryptophan

2022
Does oxidative DNA damage trigger histotoxic hypoxia via PARP1/AMP-driven mitochondrial ADP depletion-induced ATP synthase inhibition in Alzheimer's disease?
    Mitochondrion, 2022, Volume: 67

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Alzheimer Disease; DNA Damage; Humans; Hypoxia; Mitochondrial Proton-Translocating ATPases; NAD; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases

2022
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
    Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12

    Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult

2022
Apolipoprotein E4 targets mitochondria and the mitochondria-associated membrane complex in neuropathology, including Alzheimer's disease.
    Current opinion in neurobiology, 2023, Volume: 79

    Topics: Adenosine Triphosphate; Alzheimer Disease; Apolipoprotein E4; Humans; Mitochondria; NAD; Nervous System Diseases

2023
Involvement of GABAergic interneuron dysfunction and neuronal network hyperexcitability in Alzheimer's disease: Amelioration by metabolic switching.
    International review of neurobiology, 2020, Volume: 154

    Topics: Aging; Alzheimer Disease; Animals; Diet, Ketogenic; Fasting; GABAergic Neurons; Humans; Interneurons; Ketones; NAD; Nerve Net

2020
Protective Effects of Nicotinamide Adenine Dinucleotide and Related Precursors in Alzheimer's Disease: A Systematic Review of Preclinical Studies.
    Journal of molecular neuroscience : MN, 2021, Volume: 71, Issue:7

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Apoptosis; Behavior, Animal; Disease Models, Animal; Drug Evaluation, Preclinical; Energy Metabolism; Mice; Mice, Transgenic; Mitochondria; NAD; Neuroinflammatory Diseases; Neuroprotective Agents; Niacin; Niacinamide; Oxidative Stress; Protein Aggregation, Pathological; Rats; Synapses; tau Proteins

2021
Analyzing Olfactory Neuron Precursors Non-Invasively Isolated through NADH FLIM as a Potential Tool to Study Oxidative Stress in Alzheimer's Disease.
    International journal of molecular sciences, 2021, Jun-12, Volume: 22, Issue:12

    Topics: Alzheimer Disease; Animals; Antioxidants; Humans; Microscopy, Fluorescence; NAD; Olfactory Receptor Neurons; Oxidative Stress

2021
Targeting NAD
    Pharmacological research, 2018, Volume: 128

    Topics: Alzheimer Disease; Animals; Cognition; Flavonoids; Humans; NAD; Sirtuins

2018
NAD
    Trends in molecular medicine, 2017, Volume: 23, Issue:10

    Topics: Aging; Alzheimer Disease; Animals; Cardiovascular Diseases; Energy Metabolism; Humans; Muscular Atrophy; NAD; Parkinson Disease

2017
Nicotinamide adenine dinucleotide and its related precursors for the treatment of Alzheimer's disease.
    Current opinion in psychiatry, 2018, Volume: 31, Issue:2

    Topics: Aging; Alzheimer Disease; Brain; Central Nervous System; Dietary Supplements; Humans; Memory; NAD; Neuroprotective Agents; Oxidative Stress

2018
Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule.
    Biomolecules, 2019, 01-21, Volume: 9, Issue:1

    Topics: Alzheimer Disease; Animals; Cardiovascular Diseases; Diabetes Mellitus; Humans; NAD; Nicotinamide Mononucleotide; Obesity

2019
Nicotinamide riboside, a trace nutrient in foods, is a vitamin B3 with effects on energy metabolism and neuroprotection.
    Current opinion in clinical nutrition and metabolic care, 2013, Volume: 16, Issue:6

    Topics: Alzheimer Disease; Animals; Brain; Disease Models, Animal; Energy Metabolism; Humans; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Mitochondrial Turnover; Muscle, Skeletal; NAD; Neuroprotective Agents; Niacinamide; Phosphotransferases (Alcohol Group Acceptor); Pyridinium Compounds

2013
Sirtuins Link Inflammation and Metabolism.
    Journal of immunology research, 2016, Volume: 2016

    Topics: Adenosine Triphosphate; Alzheimer Disease; Animals; Cardiovascular Diseases; Energy Metabolism; Gene Expression Regulation; Homeostasis; Humans; Inflammation; Metabolic Syndrome; NAD; Oxidative Stress; Reactive Oxygen Species; Sepsis; Signal Transduction; Sirtuins

2016
Alzheimer's disease, ceramide, visfatin and NAD.
    CNS & neurological disorders drug targets, 2008, Volume: 7, Issue:6

    Topics: Alzheimer Disease; Animals; Ceramides; Humans; NAD; Nicotinamide Phosphoribosyltransferase; Oxidative Stress; Signal Transduction

2008
The role of Sirt1: at the crossroad between promotion of longevity and protection against Alzheimer's disease neuropathology.
    Biochimica et biophysica acta, 2010, Volume: 1804, Issue:8

    Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloidosis; Animals; Caloric Restriction; Humans; Longevity; NAD; Resveratrol; Sirtuin 1; Stilbenes

2010
Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications.
    Current opinion in investigational drugs (London, England : 2000), 2010, Volume: 11, Issue:10

    Topics: Alzheimer Disease; Drug Delivery Systems; Group III Histone Deacetylases; Histone Deacetylases; Humans; Longevity; Metabolic Diseases; NAD; Neurodegenerative Diseases; Saccharomyces cerevisiae; Sirtuins

2010
Shortage of lipid-radical cycles in membranes as a possible prime cause of energetic failure in aging and Alzheimer disease.
    Neurochemical research, 2007, Volume: 32, Issue:8

    Topics: Adenosine Diphosphate; Aging; Aldehydes; alpha-Tocopherol; Alzheimer Disease; Animals; Antioxidants; Apoptosis; Cell Membrane; Energy Metabolism; Fatty Acids, Unsaturated; Humans; Lipid Peroxidation; Mitochondria; Mitochondrial ADP, ATP Translocases; Molecular Structure; NAD; Oxidation-Reduction; Reactive Oxygen Species

2007

Trials

3 trial(s) available for nad and Alzheimer Disease

ArticleYear
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
    Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12

    Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult

2022
Treatment of Alzheimer's disease with stabilized oral nicotinamide adenine dinucleotide: a randomized, double-blind study.
    Drugs under experimental and clinical research, 2004, Volume: 30, Issue:1

    Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Cognition; Double-Blind Method; Humans; Middle Aged; NAD; Psychiatric Status Rating Scales; Psychological Tests; Treatment Outcome

2004
No evidence for cognitive improvement from oral nicotinamide adenine dinucleotide (NADH) in dementia.
    Journal of neural transmission (Vienna, Austria : 1996), 2000, Volume: 107, Issue:12

    Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Dementia; Dementia, Vascular; Drug Therapy, Combination; Female; Humans; Language; Male; Memory; Mental Status Schedule; Middle Aged; NAD; Orientation; Psychiatric Status Rating Scales; Psychological Tests; Treatment Failure

2000

Other Studies

36 other study(ies) available for nad and Alzheimer Disease

ArticleYear
Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's disease.
    Aging cell, 2022, Volume: 21, Issue:7

    Topics: Alzheimer Disease; Caffeine; Energy Metabolism; Humans; NAD; Niacinamide; Pyridinium Compounds

2022
Haemorheologic Enhancement of Cerebral Perfusion Improves Oxygen Supply and Reduces Aβ Plaques Deposition in a Mouse Model of Alzheimer's Disease.
    Advances in experimental medicine and biology, 2022, Volume: 1395

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Cerebrovascular Circulation; Disease Models, Animal; Hypoxia; Mice; Mice, Transgenic; NAD; Oxygen; Perfusion; Plaque, Amyloid; Polymers

2022
Hippocampal subfield volumetry in corticobasal syndrome of diverse underlying pathologies.
    Journal of neurology, 2023, Volume: 270, Issue:4

    Topics: Alzheimer Disease; Atrophy; Corticobasal Degeneration; Hippocampus; Humans; Magnetic Resonance Imaging; NAD

2023
Sex-divergent effects on the NAD+-dependent deacetylase sirtuin signaling across the olfactory-entorhinal-amygdaloid axis in Alzheimer's and Parkinson's diseases.
    Biology of sex differences, 2023, 02-08, Volume: 14, Issue:1

    Topics: Alzheimer Disease; Female; Humans; Male; NAD; Parkinson Disease; Signal Transduction; Smell

2023
A peripheral signature of Alzheimer's disease featuring microbiota-gut-brain axis markers.
    Alzheimer's research & therapy, 2023, 05-31, Volume: 15, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain-Gut Axis; Humans; Interleukin-10; Interleukin-6; Lipopolysaccharides; NAD; Platelet Endothelial Cell Adhesion Molecule-1; RNA, Ribosomal, 16S; Tumor Necrosis Factor-alpha

2023
Nicotinamide phosphoribosyltransferase‑related signaling pathway in early Alzheimer's disease mouse models.
    Molecular medicine reports, 2019, Volume: 20, Issue:6

    Topics: Acrylamides; Alzheimer Disease; Amyloid; Animals; Behavior, Animal; Cytokines; Disease Models, Animal; Hippocampus; Learning; Male; Memory; Mice; Mice, Inbred C57BL; Mice, Transgenic; NAD; Nicotinamide Phosphoribosyltransferase; Piperidines; Signal Transduction; Sirtuin 1

2019
The NAD
    Mechanisms of ageing and development, 2020, Volume: 185

    Topics: Alzheimer Disease; Artificial Intelligence; Drug Discovery; Healthy Aging; Homeostasis; Humans; Longevity; Mitochondria; Mitophagy; NAD; Organelle Biogenesis

2020
Physical exercise may exert its therapeutic influence on Alzheimer's disease through the reversal of mitochondrial dysfunction via SIRT1-FOXO1/3-PINK1-Parkin-mediated mitophagy.
    Journal of sport and health science, 2021, Volume: 10, Issue:1

    Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Brain-Derived Neurotrophic Factor; Disease Progression; Exercise; Forkhead Box Protein O1; Humans; Mitochondria; Mitochondrial Diseases; Mitophagy; NAD; Niacinamide; Nicotinamide Mononucleotide; Protein Kinases; Pyridinium Compounds; Reactive Oxygen Species; Sirtuin 1; Ubiquitin-Protein Ligases

2021
Sex-specific alterations in NAD+ metabolism in 3xTg Alzheimer's disease mouse brain assessed by quantitative targeted LC-MS.
    Journal of neurochemistry, 2021, Volume: 159, Issue:2

    Topics: Alzheimer Disease; Animals; Chromatography, High Pressure Liquid; Encephalitis; Female; Humans; Kynurenic Acid; Kynurenine; Male; Metabolome; Mice; Mice, Transgenic; NAD; Neuroprotection; Nicotinamide Mononucleotide; Sex Characteristics; Tandem Mass Spectrometry

2021
Molecular imaging of NAD
    Alzheimer's & dementia : the journal of the Alzheimer's Association, 2021, Volume: 17, Issue:12

    Topics: Aging; Alzheimer Disease; Animals; Brain; Disease Models, Animal; Mice; Mice, Transgenic; Molecular Imaging; NAD; Positron-Emission Tomography; Sirtuin 1

2021
Parp mutations protect from mitochondrial toxicity in Alzheimer's disease.
    Cell death & disease, 2021, 06-25, Volume: 12, Issue:7

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Behavior, Animal; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Humans; Metabolome; Metabolomics; Mitochondria; Motor Activity; Mutation; NAD; Nerve Degeneration; Neurons; Niacinamide; Poly (ADP-Ribose) Polymerase-1; Polymorphism, Single Nucleotide

2021
Alzheimer mouse brain tissue measured by time resolved fluorescence spectroscopy using single- and multi-photon excitation of label free native molecules.
    Journal of biophotonics, 2018, Volume: 11, Issue:1

    Topics: Absorption, Radiation; Alzheimer Disease; Animals; Brain; Flavin-Adenine Dinucleotide; Mice; NAD; Photons; Spectrometry, Fluorescence; Time Factors

2018
Label-Free Fluorescence Spectroscopy for Detecting Key Biomolecules in Brain Tissue from a Mouse Model of Alzheimer's Disease.
    Scientific reports, 2017, 06-01, Volume: 7, Issue:1

    Topics: Alzheimer Disease; Animals; Brain; Disease Models, Animal; Early Diagnosis; Flavin-Adenine Dinucleotide; Humans; Mice; Mice, Transgenic; NAD; Spectrometry, Fluorescence; Tryptophan

2017
Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity.
    Nature, 2017, 12-14, Volume: 552, Issue:7684

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Caenorhabditis elegans; Disease Models, Animal; Homeostasis; Humans; Male; Memory; Mice; Mice, Transgenic; Mitochondria; Mitophagy; NAD; Niacinamide; Oxidative Phosphorylation; Protein Aggregation, Pathological; Protein Biosynthesis; Proteostasis; Pyridinium Compounds; Unfolded Protein Response

2017
Age- and AD-related redox state of NADH in subcellular compartments by fluorescence lifetime imaging microscopy.
    GeroScience, 2019, Volume: 41, Issue:1

    Topics: Aging; Alzheimer Disease; Animals; Disease Models, Animal; Genotype; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Fluorescence; Mitochondria; NAD; Neurons; Optical Imaging; Oxidation-Reduction; Oxidative Phosphorylation; Sex Characteristics; tau Proteins

2019
Mitophagy and NAD
    Autophagy, 2019, Volume: 15, Issue:6

    Topics: Alzheimer Disease; Animals; Autophagy; Cognition; Humans; Mitophagy; NAD

2019
Ketones improves Apolipoprotein E4-related memory deficiency via sirtuin 3.
    Aging, 2019, 07-07, Volume: 11, Issue:13

    Topics: Adenosine Triphosphate; Alzheimer Disease; Animals; Apolipoprotein E3; Disks Large Homolog 4 Protein; Hippocampus; Humans; Ketones; Learning; Maze Learning; Memory Disorders; Mice; Mice, Knockout, ApoE; NAD; Neuroprotection; Sirtuin 3; Synaptophysin

2019
Global Metabolic Shifts in Age and Alzheimer's Disease Mouse Brains Pivot at NAD+/NADH Redox Sites.
    Journal of Alzheimer's disease : JAD, 2019, Volume: 71, Issue:1

    Topics: Aging; Alzheimer Disease; Animals; Brain; Caenorhabditis elegans Proteins; Carrier Proteins; Citric Acid Cycle; Disease Models, Animal; Energy Metabolism; Female; Hippocampus; Male; Metabolome; Mice; Mice, Transgenic; NAD; NADP; Oxidation-Reduction

2019
Reversibility of Age-related Oxidized Free NADH Redox States in Alzheimer's Disease Neurons by Imposed External Cys/CySS Redox Shifts.
    Scientific reports, 2019, 08-02, Volume: 9, Issue:1

    Topics: Aging; Alzheimer Disease; Animals; Cell Nucleus; Cells, Cultured; Cellular Senescence; Cysteine; Cystine; Cytoplasm; Disease Models, Animal; Energy Metabolism; Female; Hippocampus; Humans; Intravital Microscopy; Male; Mice; Mice, Transgenic; Microscopy, Fluorescence; Mitochondria; NAD; Neurons; Oxidation-Reduction; Oxidative Stress; Primary Cell Culture

2019
Dual-energy precursor and nuclear erythroid-related factor 2 activator treatment additively improve redox glutathione levels and neuron survival in aging and Alzheimer mouse neurons upstream of reactive oxygen species.
    Neurobiology of aging, 2014, Volume: 35, Issue:1

    Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Cells, Cultured; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Glutamate-Cysteine Ligase; Glutathione; Glycyrrhetinic Acid; Mice, Inbred C57BL; Mice, Transgenic; Molecular Targeted Therapy; NAD; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Niacinamide; Oxidation-Reduction; Reactive Oxygen Species

2014
Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model.
    BMC neurology, 2015, Mar-01, Volume: 15

    Topics: Alzheimer Disease; Animals; Brain; Female; Male; Mice; Mice, Transgenic; Mitochondria; NAD; Neurodegenerative Diseases; Nicotinamide Mononucleotide; Oxygen Consumption

2015
Morphology-Specific Inhibition of β-Amyloid Aggregates by 17β-Hydroxysteroid Dehydrogenase Type 10.
    Chembiochem : a European journal of chemical biology, 2016, 06-02, Volume: 17, Issue:11

    Topics: 17-Hydroxysteroid Dehydrogenases; Alzheimer Disease; Amyloid beta-Peptides; Endosomes; Fluorescent Dyes; Humans; NAD; Peptide Fragments; Recombinant Proteins; Spectrometry, Fluorescence

2016
Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
    Brain research, 2016, 07-15, Volume: 1643

    Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Death; Cognitive Dysfunction; Disease Models, Animal; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Memory; Mitochondria; NAD; Neurons; Neuroprotective Agents; Nicotinamide Mononucleotide; Peptide Fragments; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxides; Tissue Culture Techniques

2016
Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.
    Journal of Alzheimer's disease : JAD, 2016, 08-10, Volume: 54, Issue:1

    Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cell Line, Tumor; CHO Cells; Citrate (si)-Synthase; Cricetulus; Disease Models, Animal; Electron Transport Complex IV; Entorhinal Cortex; Enzyme Inhibitors; Hippocampus; Lactic Acid; Membrane Potential, Mitochondrial; Mice, Transgenic; Mitochondria; NAD; Neuroprotective Agents; Peptide Fragments; Poly (ADP-Ribose) Polymerase-1

2016
Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death.
    Brain : a journal of neurology, 2011, Volume: 134, Issue:Pt 6

    Topics: 4-Chloro-7-nitrobenzofurazan; Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Animals, Newborn; Astrocytes; Calcium; Cell Death; Coculture Techniques; Deoxyglucose; Disease Models, Animal; Glial Fibrillary Acidic Protein; Glucose; Hippocampus; Membrane Potential, Mitochondrial; Mice; Mice, Transgenic; NAD; NADPH Oxidases; Neurons; Oxygen Consumption; Peptide Fragments; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate

2011
A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012, Apr-25, Volume: 32, Issue:17

    Topics: Adenine Nucleotides; Aging; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Calcium; Cells, Cultured; Cerebral Cortex; Chromatography, High Pressure Liquid; Cytochromes c; Disease Models, Animal; Glutathione; Hippocampus; Humans; Hydrogen Peroxide; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; NAD; Neurons; Niacinamide; Oxidants; Oxidation-Reduction; Presenilin-1; Reactive Oxygen Species; tau Proteins; Vitamin B Complex

2012
Impaired hypoxic tolerance and altered protein binding of NADH in presymptomatic APP23 transgenic mice.
    Neuroscience, 2002, Volume: 114, Issue:2

    Topics: Action Potentials; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Energy Metabolism; Female; Hippocampus; Hypoxia, Brain; Ischemic Preconditioning; Male; Mice; Mice, Transgenic; NAD; Neurons; Nitro Compounds; Propionates; Protein Binding; Recovery of Function; Spectrum Analysis

2002
Subcellular alteration of glyceraldehyde-3-phosphate dehydrogenase in Alzheimer's disease fibroblasts.
    Journal of neuroscience research, 2003, Jan-15, Volume: 71, Issue:2

    Topics: Age Factors; Alzheimer Disease; Blotting, Western; Cells, Cultured; Fibroblasts; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Matched-Pair Analysis; NAD; Subcellular Fractions; Time Factors

2003
Live tissue intrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonic generation.
    Proceedings of the National Academy of Sciences of the United States of America, 2003, Jun-10, Volume: 100, Issue:12

    Topics: Alzheimer Disease; Animals; Biophysical Phenomena; Biophysics; Collagen; Female; Fluorescent Dyes; Humans; Indoles; Mammary Neoplasms, Experimental; Mice; Microscopy, Fluorescence; NAD; Neurofibrillary Tangles; Photons; Vitamin A

2003
Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease.
    Neurotoxicity research, 2003, Volume: 5, Issue:7

    Topics: Acrolein; Alzheimer Disease; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Ketoglutarate Dehydrogenase Complex; Mitochondria; NAD; Pyruvate Dehydrogenase Complex; Thioctic Acid

2003
ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.
    Science (New York, N.Y.), 2004, Apr-16, Volume: 304, Issue:5669

    Topics: 3-Hydroxyacyl CoA Dehydrogenases; Aged; Aged, 80 and over; Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Animals; Binding Sites; Brain; Brain Chemistry; Carrier Proteins; Cells, Cultured; Cerebral Cortex; Crystallization; DNA Fragmentation; Hippocampus; Humans; Learning; Memory; Mice; Mice, Transgenic; Microscopy, Confocal; Microscopy, Immunoelectron; Mitochondria; Models, Molecular; Molecular Sequence Data; Mutation; NAD; Neurons; Protein Binding; Protein Conformation; Reactive Oxygen Species

2004
Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics.
    Journal of molecular biology, 2004, Sep-17, Volume: 342, Issue:3

    Topics: 3-Hydroxyacyl CoA Dehydrogenases; Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Base Sequence; Catalytic Domain; Crystallography, X-Ray; DNA, Complementary; Drug Design; Enzyme Inhibitors; Humans; In Vitro Techniques; Kinetics; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; NAD; Protein Conformation; Protein Structure, Quaternary; Recombinant Proteins; Sequence Homology, Amino Acid

2004
Ability of carbazole salts, inhibitors of Alzheimer beta-amyloid fibril formation, to cross cellular membranes.
    European journal of pharmacology, 2007, Mar-22, Volume: 559, Issue:2-3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Carbazoles; Cell Membrane; Cell Membrane Permeability; Cell Nucleus; Circular Dichroism; Cyclic P-Oxides; DNA; Glutathione; Humans; K562 Cells; Membrane Potentials; Multidrug Resistance-Associated Proteins; NAD; Nicotinic Acids; Oxidation-Reduction; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Time Factors; Triazoles

2007
Human diseases with defects in oxidative phosphorylation. 2. F1F0 ATP-synthase defects in Alzheimer disease revealed by blue native polyacrylamide gel electrophoresis.
    European journal of biochemistry, 1995, Feb-01, Volume: 227, Issue:3

    Topics: Adenine Nucleotides; Aged; Aged, 80 and over; Alzheimer Disease; Electrophoresis, Gel, Two-Dimensional; Female; Hippocampus; Humans; Male; Membrane Proteins; Middle Aged; NAD; Oxidative Phosphorylation; Proton-Translocating ATPases

1995
Abundant type 10 17 beta-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model.
    Brain research. Molecular brain research, 2002, Feb-28, Volume: 99, Issue:1

    Topics: 17-Hydroxysteroid Dehydrogenases; 3-Hydroxyacyl CoA Dehydrogenases; Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Protein Precursor; Animals; Base Sequence; Binding Sites; Cloning, Molecular; Disease Models, Animal; DNA, Complementary; Hippocampus; Humans; Mice; Mice, Transgenic; Mitochondria; Molecular Sequence Data; NAD; Presynaptic Terminals; Protein Isoforms; Protein Structure, Tertiary; Signal Transduction; Steroids; Tryptophan

2002
Brain regional analysis of NADH-cytochrome C reductase activity in Alzheimer's disease.
    Journal of neuropathology and experimental neurology, 1990, Volume: 49, Issue:3

    Topics: Alzheimer Disease; Brain; Cerebellar Cortex; Choline O-Acetyltransferase; Cytochrome Reductases; Female; Hippocampus; Humans; Male; NAD; NADH Dehydrogenase; Temporal Lobe

1990